August 29, 2025 a 04:39 pm
DHR: Analysts Ratings - Danaher Corporation
Danaher Corporation, a leader in the healthcare and environmental solutions industry, has consistently demonstrated strong performance across its segments. The stock has seen favorable analyst ratings, reflecting confidence in its operational strategy and market position. Given the diversified nature of its business, DHR is well-positioned to capitalize on growth opportunities in the life sciences and diagnostics sectors.
Historical Stock Grades
The latest analyst ratings for Danaher Corporation, as of August 1, 2025, maintain a positive outlook with a strong concentration of Buy recommendations. This month, there are 18 Buy and 5 Strong Buy ratings, with minimal inclination towards Hold or Sell.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 5 | |
| Buy | 18 | |
| Hold | 1 | |
| Sell | 0 | |
| Strong Sell | 0 |
Historical data of analyst ratings over the past months for DHR.
Recent stock price movements for Danaher Corporation.
Sentiment Development
Over the past months, the analyst sentiment towards Danaher Corporation has remained overwhelmingly positive. The predominance of Buy and Strong Buy ratings signifies sustained confidence in the company's market strategy.
- The total analyst recommendations have been stable, supporting strong market confidence.
- Slight fluctuations in Buy recommendations over the months indicate strategic adjustments by analysts.
- Despite minor changes, Hold ratings have minimal impact, reaffirming overall positivity.
Percentage Trends
Analyst ratings for Danaher Corporation over the past months reflect a stable commitment to Buy ratings, with minor percentage shifts between categories. The consistency in Strong Buy and Buy ratings underscores the perceived market strength.
- There is a consistent decline in Hold ratings, indicating an increasing conviction in market potential.
- Currently, Strong Buy ratings comprise roughly 20-25% of total analyst opinions.
- Buy recommendations consistently represent around 60-70%, indicating analyst confidence.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-23 | Buy | Buy | Guggenheim |
| 2025-07-23 | Buy | Buy | UBS |
| 2025-07-23 | Outperform | Outperform | Baird |
| 2025-07-23 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-07-18 | Outperform | Outperform | Baird |
Analyst Recommendations with Change of Opinion
The recent changes in analyst opinions for Danaher Corporation reflect strategic adjustments and market reassessment, with both upgrades and downgrades illustrating market dynamics.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-11 | Sector Outperform | Sector Perform | Scotiabank |
| 2025-04-10 | Overweight | Equal Weight | Barclays |
| 2025-03-14 | Buy | Hold | Stifel |
| 2025-02-03 | Market Perform | Outperform | Raymond James |
| 2024-12-13 | Buy | Neutral | B of A Securities |
Interpretation
The ongoing strength in Buy and Strong Buy ratings suggests a stable positive market perception of Danaher Corporation. The consistency in analyst sentiment indicates strong operational performance and upside potential. However, recent fluctuations in ratings reveal some degree of market reassessment, which could signal either emerging opportunities or potential challenges. The general optimism in the ratings confirms the company's robust positioning within its sectors, although minor variations in Hold and reduced Strong Buy ratings may hint at a cautious, yet still confident, outlook.
Conclusion
Danaher Corporation continues to enjoy favorable sentiments among analysts with a strong bias towards Buy recommendations, illustrating high expectations for future growth prospects. While some shifts in recommendations are evident, they reflect typical market dynamism rather than fundamental concerns. The company's diversified operations across critical sectors present both opportunities and moderate risks, but the overarching sentiment suggests a well-managed growth trajectory. Analysts maintain a consistent and supportive stance, indicating robust confidence in DHR's strategic direction and execution in the foreseeable future.